Concepta PLC (LON:FRI) had its price target trimmed by Liberum Capital from GBX 1,250 ($16.14) to GBX 850 ($10.98) in a research report released on Thursday, StockTargetPrices.com reports. The brokerage currently has a buy rating on the stock.
Other equities analysts have also recently issued research reports about the stock. Numis Securities Ltd upgraded shares of Concepta PLC to an add rating and lifted their target price for the stock from GBX 300 ($3.87) to GBX 466 ($6.02) in a research report on Thursday, June 22nd. Peel Hunt restated a buy rating and set a GBX 120 ($1.55) target price on shares of Concepta PLC in a research report on Monday, September 4th. Finally, FinnCap lifted their target price on shares of Concepta PLC from GBX 690 ($8.91) to GBX 968 ($12.50) and gave the stock a corporate rating in a research report on Monday, August 21st.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by Markets Daily and is owned by of Markets Daily. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.themarketsdaily.com/2017/09/11/concepta-plc-fri-price-target-cut-to-gbx-850-by-analysts-at-liberum-capital.html.
About Concepta PLC
Concepta PLC, formerly Frontier Resources International Plc, is a healthcare company. The Company is involved in the development of products and a platform, which targets the personalized mobile health market with a focus on women’s fertility and unexplained infertility. The Company’s portfolio of products includes MyLotus Meter, Ovulation Test, Pregnancy Test and Fertility App.
Receive News & Ratings for Concepta PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concepta PLC and related companies with MarketBeat.com's FREE daily email newsletter.